The Effect of Physical Therapy Program and Erector Spina Plane Block in Patients With Degenerative Lumbar Scoliosis
Low Back Pain
About this trial
This is an interventional treatment trial for Low Back Pain focused on measuring Degenerative lumbar scoliosis, Physical treatment, Erector spinae plane block, Low back pain
Eligibility Criteria
Inclusion Criteria: Being 60 years or older Having a scoliosis of 10 degrees or more in the lumbar region according to the measurement made with the cobb method Having pain in the axial waist or radiating from the waist to the leg Pain that persists for at least 3 months NRS > 4 Exclusion Criteria: Systemic or local infection at the injection site Past or current history of malignant disease Presence of neurological or orthopedic disease Presence of uncontrolled hypertension, diabetes mellitus Presence of severe heart failure Presence of bleeding diathesis Anticoagulant use Lidocaine allergy Psychiatric disorder or mental problem inflammatory spine pain Severe osteoporosis / previous vertebral fracture Body mass index >35 Having had previous surgery on the lumbar region Injection was applied to the waist region within 6 months or physical have been treated
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
physical therapy
physical therapy + espb
The physical therapy program is planned as a total of 15 sessions in the lumbar region, each session consisting of TENS (50-100 Hz stimulation frequency, 200 µs pulse duration, intensity is increased as much as the patient could tolerate, 20 minutes in total), hotpack (to be placed on the painful area, 20 minutes), US (1 mHz frequency, 10 minutes, 1.5 watt/cm2 intensity)
same physical therapy program, in addition Ultrasound-guided lumbar ESPB is performed using an in-line cephalic approach, and after contacting the corner of the L3 transverse process, a small dose of saline is injected into the fascial space between the L3 transverse process and the erector spinae muscles to "lift off" the fascia. After verification, a mixture of 20 mL of 1% lidocaine and 3 mg betamethasone is administered for unilateral injection. The procedure is performed bilaterally.